Immediate post-procedure bridging with unfractioned heparin versus low molecular weight heparin in patients undergoing radiofrequency ablation for atrial fibrillation with an interrupted oral anticoagulation strategy

详细信息    查看全文

• 作者：Gerard Loughlin ; Tomás Datino Romaniega…
• 关键词：Atrial fibrillation ; Radiofrequency ablation ; Anticoagulation ; Heparin ; Protamine
• 刊名：Journal of Interventional Cardiac Electrophysiology
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：45
• 期：2
• 页码：149-158
• 全文大小：602 KB
• 参考文献：1.Jaïs, P., Haïssaguerre, M., Shah, D. C., Chouairi, S., Gencel, L., Hocini, M., et al. (1997). A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation, 95(3), 572–576.CrossRef PubMed
  2.Calkins, H. (2012). Catheter ablation to maintain sinus rhythm. Circulation, 125(11), 1439–1445.CrossRef PubMed
  3.Calkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S., et al. (2012). HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace, 14(4), 528–606.CrossRef PubMed
  4.Hussein, A. A., Martin, D. O., Saliba, W., Patel, D., Karim, S., Batal, O., et al. (2009). Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: a safe and efficacious periprocedural anticoagulation strategy. Heart Rhythm, 6, 1425–1429.CrossRef PubMed
  5.Kwak, J. J., Pak, H. N., Jang, J. K., Kim, S. K., Park, J. H., Choi, J. I., Hwang, C., & Kim, Y. H. (2010). Safety and convenience of continuous warfarin strategy during the periprocedural period in patients who underwent catheter ablation of atrial fibrillation. Journal of Cardiovascular Electrophysiology, 21(6), 620–625.CrossRef PubMed
  6.Di Biase, L., Burkhardt, J. D., Santangeli, P., Mohanty, P., Sanchez, J. E., Horton, R., Gallinghouse, G. J., Themistoclakis, S., Rossillo, A., Lakkireddy, D., Reddy, M., Hao, S., Hongo, R., Beheiry, S., Zagrodzky, J., Rong, B., Mohanty, S., Elayi, C. S., Forleo, G., Pelargonio, G., Narducci, M. L., Dello Russo, A., Casella, M., Fassini, G., Tondo, C., Schweikert, R. A., & Natale, A. (2014). Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial. Circulation, 129(25), 2638–2644.CrossRef PubMed
  7.Arshad, A., Johnson, C. K., Mittal, S., Buch, E., Hamam, I., Tran, T., Shaw, R. E., Musat, D., Preminger, M., Sichrovsky, T., Herweg, B., Shivkumar, K., Hummel, J., & Steinberg, J. S. (2014). Comparative safety of periablation anticoagulation strategies for atrial fibrillation: data from a large multicenter study. Pacing and Clinical Electrophysiology, 37(6), 665–673.PubMedCentral CrossRef PubMed
  8.Winkle, R. A. (2014). Uninterrupted warfarin anticoagulation for atrial fibrillation ablation: too good to be true? Pacing and Clinical Electrophysiology, 37(6), 661–664.CrossRef PubMed
  9.Blanc, J. J., Almendral, J., Brignole, M., Fatemi, M., Gjesdal, K., González-Torrecilla, E., et al. (2008). Scientific Initiatives Committee of the European Heart Rhythm Association. Consensus document on antithrombotic therapy in the setting of electrophysiological procedures. Europace, 10(5), 513–527.CrossRef PubMed
  10.Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., & Roth, D. (1999). A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Annals of Internal Medicine, 130(6), 461–470.CrossRef PubMed
  11.Scherr, D., Sharma, K., Dalal, D., et al. (2009). Incidence and predictors of periprocedural cerebrovascular accident in patients undergoing catheter ablation of atrial fibrillation. Journal of Cardiovascular Electrophysiology, 20(12), 1357–1363.CrossRef PubMed
  12.Vazquez, S. R., Johnson, S. A., & Rondina, M. T. (2010). Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation. Thrombosis Research, 126(2), e69–e77.PubMedCentral CrossRef PubMed
  13.Cappato, R., Calkins, H., Chen, S. A., Davies, W., Iesaka, Y., Kalman, J., Kim, Y. H., Klein, G., Natale, A., Packer, D., Skanes, A., Ambrogi, F., & Biganzoli, E. (2010). Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. Arrhythmia and Electrophysiology, 3(1), 32–38.CrossRef PubMed
  14.Srivatsa, U. N., Danielsen, B., Anderson, I., Amsterdam, E., Pezeshkian, N., Yang, Y., & White, R. H. (2014). Risk predictors of stroke and mortality after ablation for atrial fibrillation: the California experience 2005-2009. Heart Rhythm, 11(11), 1898–1903.CrossRef PubMed
  15.Kosiuk, J., Kornej, J., Bollmann, A., Piorkowski, C., Myrda, K., Arya, A., Sommer, P., Richter, S., Rolf, S., Husser, D., Gaspar, T., Lip, G. Y., & Hindricks, G. (2014). Early cerebral thromboembolic complications after radiofrequency catheter ablation of atrial fibrillation: incidence, characteristics, and risk factors. Heart Rhythm, 11(11), 1934–1940.CrossRef PubMed
  16.Dorwarth, U., Fiek, M., Remp, T., Reithmann, C., Dugas, M., Steinbeck, G., & Hoffmann, E. (2003). Radiofrequency catheter ablation: different cooled and noncooled electrode systems induce specific lesion geometries and adverse effects profiles. Pacing and Clinical Electrophysiology, 26(7 Pt 1), 1438–1445.CrossRef PubMed
  17.Maleki, K., Mohammadi, R., Hart, D., Cotiga, D., Farhat, N., & Steinberg, J. S. (2005). Intracardiac ultrasound detection of thrombus on transseptal sheath: incidence, treatment, and prevention. Journal of Cardiovascular Electrophysiology, 16(6), 561–565.CrossRef PubMed
  18.Wazni, O. M., Rossillo, A., Marrouche, N. F., Saad, E. B., Martin, D. O., Bhargava, M., Bash, D., Beheiry, S., Wexman, M., Potenza, D., Pisano, E., Fanelli, R., Bonso, A., Themistoclakis, S., Erciyes, D., Saliba, W. I., Schweikert, R. A., Brachmann, J., Raviele, A., & Natale, A. (2005). Embolic events and char formation during pulmonary vein isolation in patients with atrial fibrillation: impact of different anticoagulation regimens and importance of intracardiac echo imaging. Journal of Cardiovascular Electrophysiology, 16(6), 576–581.CrossRef PubMed
  19.Sparks, P. B., Jayaprakash, S., Vohra, J. K., Mond, H. G., Yapanis, A. G., Grigg, L. E., & Kalman, J. M. (1998). Left atrial "stunning" following radiofrequency catheter ablation of chronic atrial flutter. Journal of the American College of Cardiology, 32(2), 468–475.CrossRef PubMed
  20.Di Biase, L., Gaita, F., Toso, E., Santangeli, P., Mohanty, P., Rutledge, N., Yan, X., Mohanty, S., Trivedi, C., Bai, R., Price, J., Horton, R., Gallinghouse, G. J., Beheiry, S., Zagrodzky, J., Canby, R., Leclercq, J. F., Halimi, F., Scaglione, M., Cesarani, F., Faletti, R., Sanchez, J., Burkhardt, J. D., & Natale, A. (2014). Does periprocedural anticoagulation management of atrial fibrillation affect the prevalence of silent thromboembolic lesion detected by diffusion cerebral magnetic resonance imaging in patients undergoing radiofrequency atrial fibrillation ablation with open irrigated catheters? Results from a prospective multicenter study. Heart Rhythm, 11(5), 791–798.CrossRef PubMed
  21.Deneke, T., Jais, P., Scaglione, M., Schmitt, R., DI Biase, L., Christopoulos, G., Schade, A., Mügge, A., Bansmann, M., Nentwich, K., Müller, P., Krug, J., Roos, M., Halbfass, P., Natale, A., Gaita, F., & Haines, D. (2015). Silent cerebral events/lesions related to atrial fibrillation ablation: a clinical review. Journal of Cardiovascular Electrophysiology, 26(4), 455–463.CrossRef PubMed
  22.Page, S., Herring, N., Hunter, R., Withycombe, E., Lovell, M., Wali, G., Betts, T., Bashir, Y., Dhinoja, M., Earley, M., Sporton, S., Rajappan, K., & Schilling, R. (2014). Periprocedural stroke risk in patients undergoing catheter ablation for atrial fibrillation on uninterrupted warfarin. Journal of Cardiovascular Electrophysiology, 25, 585–590.CrossRef PubMed
  23.Patel, A. A., Clyne, C. A., Henyan, N. N., White, C. M., Zembrowski, B. F., Migeed, M., Yarlagadda, R., Kluger, J., & Coleman, C. I. (2007). The use of protamine after radiofrequency catheter ablation: a pilot study. Journal of Interventional Cardiac Electrophysiology, 18(2), 155–158.CrossRef PubMed
  24.Gurses, K. M., Kocyigit, D., Yalcin, M. U., Evranos, B., Yorgun, H., Sahiner, M. L., Kaya, E. B., Oto, M. A., Ozer, N., & Aytemir, K. (2015). Safety and efficacy outcomes of protamine administration for heparin reversal following cryoballoon-based pulmonary vein isolation. Journal of Interventional Cardiac Electrophysiology, 43(2), 161–167.CrossRef PubMed
  25.Conte, G., de Asmundis, C., Baltogiannis, G., Di Giovanni, G., Ciconte, G., Sieira, J., Saitoh, Y., Wauters, K., Mugnai, G., Julià, J., Irfan, G., Levinstein, M., Cotino-Moreno, H. E., Chierchia, G. B., & Brugada, P. (2014). Periprocedural outcomes of prophylactic protamine administration for reversal of heparin after cryoballoon ablation of atrial fibrillation. Journal of Interventional Cardiac Electrophysiology, 41(2), 129–134.CrossRef PubMed
  26.Chilukuri, K., Henrikson, C. A., Dalal, D., Scherr, D., MacPherson, E. C., Cheng, A., Spragg, D., Nazarian, S., Sinha, S., Berger, R., Marine, J. E., & Calkins, H. (2009). Incidence and outcomes of protamine reactions in patients undergoing catheter ablation of atrial fibrillation. Journal of Interventional Cardiac Electrophysiology, 25(3), 175–181.CrossRef PubMed
  
• 作者单位：Gerard Loughlin (1)
  Tomás Datino Romaniega (1)
  Javier Garcia-Fernandez (2)
  David Calvo (3)
  Ricardo Salgado (2)
  Andres Alonso (1)
  Xin Li (1)
  Angel Arenal (1)
  Esteban González-Torrecilla (1)
  Felipe Atienza (1)
  Francisco Fernández-Avilés (1)
  
  1. Department of Cardiology, Instituto de Investigación Sanitaria del Hospital General Universitario Gregorio Marañón, Hospital General Universitario Gregorio Marañón, C/Dr. Esquerdo 46, 28007, Madrid, Spain
  2. Hospital Universitario Asistencial, Burgos, Spain
  3. Hospital Universitario Central de Asturias, Oviedo, Spain
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Cardiology
  
• 出版者：Springer Netherlands
• ISSN：1572-8595

文摘

Purpose Many centers perform catheter ablation for atrial fibrillation (AF) with periprocedural interruption of oral vitamin K antagonists. In this scenario, the optimal post-procedural anticoagulation strategy is still under debate. We sought to compare the incidence of major complications associated with post-procedural use of low molecular weight heparin (LMWH) versus unfractioned heparin (UFH) as a bridge to reinitiation of oral anticoagulation after an AF ablation procedure.